
VolitionRX Ltd (VNRX) rating initates by H.C. Wainwright
VolitionRX Ltd’s filing revealed that its President and CEO Reynolds Cameron John acquired Company’s shares for reported $9885.0 on Sep
VolitionRX Ltd’s filing revealed that its President and CEO Reynolds Cameron John acquired Company’s shares for reported $9885.0 on Sep
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
VolitionRX Ltd’s recent filing unveils that its President and CEO Reynolds Cameron John acquired Company’s shares for reported $9885.0 on
VolitionRX Ltd’s recently made public that its Director Innes Guy Archibald acquired Company’s shares for reported $50000.0 on Aug 05
In a filing, VolitionRX Ltd revealed its Director Innes Guy Archibald acquired Company’s shares for reported $50000.0 on Aug 05
VolitionRX Ltd’s filing revealed that its Director Innes Guy Archibald acquired Company’s shares for reported $50000.0 on Aug 05 ’25.
After signing a global supply agreement, VolitionRx Limited (NYSE: VNRX) increased 19.31% to $1.73 in the current market on Thursday.